AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

Which one would you pick: a great stonewalling effort against Muralitharan on a fifth-day Galle pitch or a display of supreme ...